Charles S. Berkman - 15 Feb 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
SVP, Gen. Counsel & Secretary
Signature
Charles S. Berkman
Issuer symbol
LGND
Transactions as of
15 Feb 2022
Transactions value $
-$195,167
Form type
4
Filing time
16 Feb 2022, 19:24:20
Previous filing
28 Jan 2022
Next filing
09 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$45.5K -368 -1.15% $123.68 31.6K 15 Feb 2022 Direct F1
transaction LGND Common Stock Tax liability -$78.3K -633 -2% $123.68 31K 15 Feb 2022 Direct F2
transaction LGND Common Stock Tax liability -$71.4K -577 -1.86% $123.68 30.4K 15 Feb 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2019.
F2 Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/13/2020.
F3 Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/03/2021.